+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Saccharomyces boulardii: a treatment of pseudomembranous colitis?

Saccharomyces boulardii: a treatment of pseudomembranous colitis?

Presse Medicale 18(26): 1299

ISSN/ISBN: 0755-4982

PMID: 2528139

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 041299417

Download citation: RISBibTeXText

Related references

Saccharomyces boulardii in the prevention of pseudomembranous colitis. Journal of Pharmacy Technology 18(1): 3-8, 2002

Saccharomyces boulardii prevents recurrent Clostridium difficile pseudomembranous colitis and diarrhea A multicenter controlled trial. Gastroenterology 104(4 Suppl. ): A786, 1993

Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study. Journal of General Microbiology 136(6): 1085-1089, 1990

Effect of oral Saccharomyces boulardii treatment on experimental pseudomembranous caecitis due to Clostridium difficile. Microbial Ecology in Health and Disease 2(6): XXI, 1992

Saccharomyces boulardii for the treatment of Clostridium difficile-associated colitis. Annals of PharmacoTherapy 31(7-8): 919-921, 1997

Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. American Journal of Gastroenterology 84(10): 1285-1287, 1989

Effectiveness of Saccharomyces boulardii in a rat model of colitis. World Journal of Gastroenterology 18(44): 6452, 2012

A pilot trial of Saccharomyces boulardii in ulcerative colitis. European Journal of Gastroenterology and Hepatology 15(6): 697-698, 2003

Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Digestive Diseases and Sciences 35(7): 897-901, 1990

Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis. Journal of Clinical Gastroenterology 44(5): 385, 2010

Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice. Molecular Medicine Reports 18(6): 5652-5662, 2018

A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii. Pharmacological Research 97: 48-63, 2015

Bacterio-pharmacological activity of Saccharomyces boulardii in clindamycin-induced colitis in the hamster. Arzneimittel-Forschung 34(7): 794-797, 1984

Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host. Intensive Care Medicine 26(6): 825, 2000

Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. Journal of Clinical Gastroenterology 36(1): 41-43, 2003